Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 02, 2022

BUY
$79.4 - $116.36 $56,691 - $83,081
714 Added 23.22%
3,789 $302,000
Q1 2022

Apr 28, 2022

BUY
$86.42 - $109.81 $21,864 - $27,781
253 Added 8.97%
3,075 $324,000
Q4 2021

Feb 10, 2022

BUY
$98.56 - $119.91 $7,293 - $8,873
74 Added 2.69%
2,822 $304,000
Q3 2021

Oct 26, 2021

BUY
$91.91 - $110.37 $252,568 - $303,296
2,748 New
2,748 $301,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Financial Counselors Inc Portfolio

Follow Financial Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Counselors Inc with notifications on news.